Clinical Trial Update: Pharmacokinetic, Safety and Tolerability Study of Aclidinium/Formoterol Fixed Dose Combination and Formoterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 2]

View source ↗

Summary

This Phase 2 trial assessed pharmacokinetics, safety and tolerability of the aclidinium/formoterol fixed-dose combination and of formoterol in patients with mod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Aclidinium/Formoterol Fixed Dose Combination (aclidinium/formoterol fixed-dose combination)
• Formoterol (formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: COMPLETED | Results posted: 2016-11-23